Cargando…
A novel DSN‐based fluorescence assay for MicroRNA‐133a detection and its application for LVH diagnosis in maintenance hemodialysis patients
Left ventricular hypertrophy (LVH) is the most powerful predictor of cardiovascular mortality in maintenance hemodialysis (MHD) patients. Circulating microRNA‐133a (miR‐133a) was reported to be a potential biomarker for LVH in MHD patients. The aim of this experiment is to establish a novel DSN (dup...
Autores principales: | Huang, Pei, Guo, Xuedan, Jin, Yan, Huang, Qing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7595923/ https://www.ncbi.nlm.nih.gov/pubmed/32677047 http://dx.doi.org/10.1002/jcla.23438 |
Ejemplares similares
-
The effect of intensive hemodialysis on LVH regression and blood pressure control in ESRD patients
por: Darabi, Forough, et al.
Publicado: (2020) -
Highly Sensitive Fluorescence Assay for miRNA Detection:
Investigation of the DNA Spacer Effect on the DSN Enzyme Activity
toward Magnetic-Bead-Tethered Probes
por: Djebbi, Khouloud, et al.
Publicado: (2022) -
Fibrosis quantification in Hypertensive Heart Disease with LVH and Non-LVH: Findings from T1 mapping and Contrast-free Cardiac Diffusion-weighted imaging
por: Wu, Lian-Ming, et al.
Publicado: (2017) -
Decreased Level of Blood MicroRNA-133b in Men with Opioid Use Disorder on Methadone Maintenance Therapy
por: Hsu, Chih-Wei, et al.
Publicado: (2019) -
Speckle tracking: distinction of physiologic from pathologic LVH?
por: van der Wall, E. E., et al.
Publicado: (2010)